Are there any recent studies on the impact of pharmacogenomic testing for psychiatric patients and their medications?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18239014
Cited by: 0

Abstract

Current evidence for the impact of pharmacogenomic testing in psychiatric medication management shows minimal clinical benefits, with many studies indicating no significant improvements over standard care.

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Genetic Associations and Epidemiology Drug-Induced Adverse Reactions

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
7 January 2026